Literature DB >> 25227844

Evaluation of the radiation pneumonia development risk in lung cancer cases.

Sercan Yilmaz1, Yasemin Guzle Adas, Ayse Hicsonmez, Meltem Nalca Andrieu, Serap Akyurek, Saban Cakir Gokce.   

Abstract

BACKGROUND: Concurrent chemo-radiotherapy is the recommended standard treatment modality for patients with locally advanced lung cancer. The purpose of three-dimensional conformal radiotherapy (3DCRT) is to minimize normal tissue damage while a high dose can be delivered to the tumor. The most common dose limiting side effect of thoracic RT is radiation pneumonia (RP). In this study we evaluated the relationship between dose-volume histogram parameters and radiation pneumonitis. This study targeted prediction of the possible development of RP and evaluation of the relationship between dose-volume histogram (DVH) parameters and RP in patients undergoing 3DCRT.
MATERIALS AND METHODS: DVHs of 41 lung cancer patients treated with 3DCRT were evaluated with respect to the development of grade ≥ 2 RP by excluding gross tumor volume (GTV) and planned target volume (PTV) from total (TL) and ipsilateral (IPSI) lung volume.
RESULTS: Were admitted statistically significant for p<0.05.
CONCLUSIONS: The cut-off values for V5, V13, V20, V30, V45 and the mean dose of TL-GTV; and V13, V20,V30 and the mean dose of TL-PTV were statistically significant for the development of Grade ≥ 2 RP. No statistically significant results related to the development of Grade ≥ 2 RP were observed for the ipsilateral lung and the evaluation of PTV volume. A controlled and careful evaluation of the dose-volume histograms is important to assess Grade ≥ 2 RP development of the lung cancer patients treated with concurrent chemo-radiotherapy. In the light of the obtained data it can be said that RP development may be avoided by the proper analysis of the dose volume histograms and the application of optimal treatment plans.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25227844     DOI: 10.7314/apjcp.2014.15.17.7371

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Single-nucleotide polymorphisms of TGFβ1 and ATM associated with radiation-induced pneumonitis: a prospective cohort study of thoracic cancer patients in China.

Authors:  Ying Xiao; Xianglin Yuan; Hong Qiu; Qianxia Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study.

Authors:  Xinglu Xu; Xin Ye; Gang Liu; Tingping Zhang
Journal:  Med Oncol       Date:  2015-08-05       Impact factor: 3.064

3.  Croton Tiglium Extract Induces Apoptosis via Bax/Bcl-2 Pathways in Human Lung Cancer A549 Cells

Authors:  Changyou Li; Xiao Wu; Rongli Sun; Peng Zhao; Fengjuan Liu; Chunling Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

4.  The efficacy and safety of Xuebijing injection in the treatment of radiation pneumonitis: A protocol for systematic review and meta-analysis.

Authors:  Zheng Li; Dandan Wang; Ying Zhang; Shuo Wang; Xueqian Wang; Yuxiao Li; Yuerong Gui; Jun Dong; Wei Hou
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

5.  Estimation of the risk of secondary malignancy arising from whole-breast irradiation: comparison of five radiotherapy modalities, including TomoHDA.

Authors:  Eun Young Han; Nava Paudel; Jiwon Sung; Myonggeun Yoon; Weon Kuu Chung; Dong Wook Kim
Journal:  Oncotarget       Date:  2016-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.